Adefovir dipivoxil
Adefovir dipivoxil, previously called bis-POM PMEA, with trade names Preveon and Hepsera, is an orally-administered acyclic nucleotide analog reverse transcriptase inhibitor (ntRTI) used for treatment of hepatitis B. It is ineffective against HIV-1. Adefovir dipivoxil is the diester prodrug of adefovir.
Product Specifications
CAS Number
142340-99-6
Product Name Alternative
GS 840, GS-0840, Hepsera | Preveon.
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
Ethanol: 100 mg/mL (199.41 mM) ; DMSO: 100 mg/mL (199.41 mM)
Smiles
CC (C) (C) C (=O) OCOP (=O) (COCCN1C=NC2=C1N=CN=C2N) OCOC (=O) C (C) (C) C
Molecular Formula
C20H32N5O8P
Molecular Weight
501.47
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
[2- (6-aminopurin-9-yl) ethoxymethyl- (2,2-dimethylpropanoyloxymethoxy) phosphoryl]oxymethyl 2,2-dimethylpropanoate
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
OAAF05565-100UG - OSR1 Antibody (Phospho-Thr185)
